Literature DB >> 33817171

CB2 Receptor Agonist JWH133 Activates AMPK to Inhibit Growth of C6 Glioma Cells.

Feng Wang1, Jing Wang2, Tong Zhao3, Yi Zhang3, Qian Li3,1.   

Abstract

It has been reported that endocannabinoid receptor type 2 (CB2) agonist JWH133 inhibits the growth of C6 glioma cells, but the underlying mechanism has not yet been fully elucidated. We showed that JWH133 inhibited C6 cells growth, reduced cAMP production and inhibited PKA activity through CB2 receptor. Decrease of PKA activity stimulated CaMKKβ, and subsequently elevated phosphorylation of AMPKα at threonine 172 site. The activation of AMPKα induced changes of downstream proteins, including increase of P53 phosphorylation and P21 production, as well as decrease of mTOR phosphorylation, that eventually inhibited C6 cells growth.
© 2019 Feng Wang et al., published by De Gruyter.

Entities:  

Keywords:  AMPK; C6 glioma cells; CaMKK; JWH133; cAMP-PKA; endocannabinoid receptor type 2

Year:  2019        PMID: 33817171      PMCID: PMC7874763          DOI: 10.1515/biol-2019-0041

Source DB:  PubMed          Journal:  Open Life Sci        ISSN: 2391-5412            Impact factor:   0.938


  31 in total

1.  Inhibition of glioma growth in vivo by selective activation of the CB(2) cannabinoid receptor.

Authors:  C Sánchez; M L de Ceballos; T Gomez del Pulgar; D Rueda; C Corbacho; G Velasco; I Galve-Roperh; J W Huffman; S Ramón y Cajal; M Guzmán
Journal:  Cancer Res       Date:  2001-08-01       Impact factor: 12.701

2.  Cell cycle regulation via p53 phosphorylation by a 5'-AMP activated protein kinase activator, 5-aminoimidazole- 4-carboxamide-1-beta-D-ribofuranoside, in a human hepatocellular carcinoma cell line.

Authors:  K Imamura; T Ogura; A Kishimoto; M Kaminishi; H Esumi
Journal:  Biochem Biophys Res Commun       Date:  2001-09-21       Impact factor: 3.575

3.  β-Caryophyllene attenuates palmitate-induced lipid accumulation through AMPK signaling by activating CB2 receptor in human HepG2 hepatocytes.

Authors:  Ryosuke Kamikubo; Kenji Kai; Kentaro Tsuji-Naito; Mitsugu Akagawa
Journal:  Mol Nutr Food Res       Date:  2016-06-16       Impact factor: 5.914

Review 4.  Pharmacological actions of cannabinoids.

Authors:  R G Pertwee
Journal:  Handb Exp Pharmacol       Date:  2005

5.  Activity of Sanguinarine against Candida albicans Biofilms.

Authors:  Hua Zhong; Dan-Dan Hu; Gan-Hai Hu; Juan Su; Shuang Bi; Zhuo-Er Zhang; Zheng Wang; Ri-Li Zhang; Zheng Xu; Yuan-Ying Jiang; Yan Wang
Journal:  Antimicrob Agents Chemother       Date:  2017-04-24       Impact factor: 5.191

6.  Anti-tumoral action of cannabinoids on hepatocellular carcinoma: role of AMPK-dependent activation of autophagy.

Authors:  D Vara; M Salazar; N Olea-Herrero; M Guzmán; G Velasco; I Díaz-Laviada
Journal:  Cell Death Differ       Date:  2011-04-08       Impact factor: 15.828

7.  Growth and molecular profile of lung cancer cells expressing ectopic LKB1: down-regulation of the phosphatidylinositol 3'-phosphate kinase/PTEN pathway.

Authors:  Ana I Jimenez; Paloma Fernandez; Orlando Dominguez; Ana Dopazo; Montserrat Sanchez-Cespedes
Journal:  Cancer Res       Date:  2003-03-15       Impact factor: 12.701

8.  AMP-activated protein kinase activators can inhibit the growth of prostate cancer cells by multiple mechanisms.

Authors:  Xiaoqin Xiang; Asish K Saha; Rong Wen; Neil B Ruderman; Zhijun Luo
Journal:  Biochem Biophys Res Commun       Date:  2004-08-13       Impact factor: 3.575

Review 9.  Advances in chemotherapy for brain tumors.

Authors:  C A Conrad; V P Milosavljevic; W K Yung
Journal:  Neurol Clin       Date:  1995-11       Impact factor: 3.806

10.  Inhibition of tumor angiogenesis by cannabinoids.

Authors:  Cristina Blázquez; M Llanos Casanova; Anna Planas; Teresa Gómez Del Pulgar; Concepción Villanueva; María J Fernández-Aceñero; Julián Aragonés; John W Huffman; José L Jorcano; Manuel Guzmán
Journal:  FASEB J       Date:  2003-01-02       Impact factor: 5.191

View more
  1 in total

1.  Cannabinoids pharmacological effects are beyond the palliative effects: CB2 cannabinoid receptor agonist induced cytotoxicity and apoptosis in human colorectal cancer cells (HT-29).

Authors:  Aylar Alenabi; Hassan Malekinejad
Journal:  Mol Cell Biochem       Date:  2021-04-22       Impact factor: 3.396

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.